// App-Quantinova.ai

11341 : The Newly Designed Dual Guanylyl Cyclase A and B Activator, CU-NP, Elicits Favorable Cardiorenal Hemodynamic Actions without Hypotension and Activates the Second Messenger cGMP in Isolated Cardiac Fibroblasts and Glomeruli

Researchers

Presenter

  • Candace Y W Lee

Principal Investigators

  • Sharon M Sandberg

  • Guido Boerrigter

  • Alessandro Cataliotti

  • John C Burnett Jr

Medical Centers

  • Mayo Clinic, Rochester, MN

  • Pierrefonds, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • Angiotensin II

  • Ularitide

  • CU-NP

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved